“To earn the trust of the medical fraternity and patients through concern, care and cure”.
…Time to Target Positives
  • Teicoplanin, the cutting edge glycopeptide antibiotic with its dual mode of action – inhibiting cell wall synthesis and bacterial RNA synthesis, is the drug of choice in moderate to severe infections caused by S. aureus ( MRSA, MSSA) and other susceptible MDR pathogens.

  • S. aureus sepsis
  • Burns
  • Pneumonia
  • Skin & Soft Tissue Infection
  • Urinary Tract Infection
  • Bone & Joint Infections

  • Adult:- 1Vial of 400mg as loading dose followed by 200mg as maintenance
  • Children:- Mean Doses of 3mg/kg & 6mg/kg body wt & in Severe Endocarditis: 12mg/kg

Copyrights @ 2012 : Zyphar's Pharmaceutics